EMAIL THIS PAGE TO A FRIEND

Biochemical and biophysical research communications

Ambra1 modulates starvation-induced autophagy through AMPK signaling pathway in cardiomyocytes.


PMID 25117440

Abstract

Recent research has revealed a role for Ambra1, an autophagy-related gene-related (ATG) protein, in the autophagic pro-survival response, and Ambra1 has been shown to regulate Beclin1 and Beclin1-dependent autophagy in embryonic stem cells and cancer cells. However, whether Ambra1 plays an important role in the autophagy pathway in cardiomyocytes is unknown. In this study, we hypothesized that Ambra1 is an important regulator of autophagy and apoptosis in cardiomyocytes. To test this hypothesis, we confirmed autophagic activity in serum-starved cardiomyocytes by assessing endogenous microtubule-associated protein 1 light chain 3 (LC3) localization, the presence of autophagosomes and LC3 protein levels. Cell apoptosis and viability were measured by annexin-V and PI staining and MTT assays. We determined that serum deprivation-induced autophagy was associated with Ambra1 upregulation in cardiomyocytes. When Ambra1 expression was reduced by siRNA, the cardiomyocytes were more sensitive to staurosporine-induced apoptosis. In addition, co-immunoprecipitation of Ambra1 and Beclin1 demonstrated that Ambra1 and Beclin1 interact in serum-starved or rapamycin-treated cardiomyocytes, suggesting that Ambra1 regulates autophagy in cardiomyocytes by interacting with Beclin1. Finally, we determined that starvation stress-induced activation of Ambra1 contributes to the attenuation of adaptive AMP-activated protein kinase (AMPK) signaling. In conclusion, Ambra1 is a crucial regulator of autophagy and apoptosis through AMPK signaling pathway in cardiomyocytes that maintains the balance between autophagy and apoptosis.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

AV36578
Anti-ANXA3 (AB1) antibody produced in rabbit, IgG fraction of antiserum
AV36579
Anti-ANXA3 (AB2) antibody produced in rabbit, IgG fraction of antiserum
SAB1405458
Anti-ANXA3 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA013398
Anti-ANXA3 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA013431
Anti-ANXA3 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1305638 ANTI-LC3 (APG8A) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
L8793
Anti-LC3A antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB1408113
Anti-MAP1LC3A antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA007649
Anti-MAP1LC3A antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2101425
Anti-MAP1LC3A antibody produced in rabbit, affinity isolated antibody
SAB4300571
Anti-MAP1LC3A antibody produced in rabbit, affinity isolated antibody
SAB1411514
Anti-MAP1LC3A antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB3501064
Anti-MAP1LC3A antibody produced in rabbit, affinity isolated antibody
WH0000306M12
Monoclonal Anti-ANXA3 antibody produced in mouse, clone 4F1, purified immunoglobulin, buffered aqueous solution
SAB1403553
Monoclonal Anti-ANXA3 antibody produced in mouse, clone 1E2, purified immunoglobulin, buffered aqueous solution
SAB4100143
Monoclonal Anti-ANXA3 antibody produced in mouse, clone ANXA3-A107, culture supernatant
WH0084557M7
Monoclonal Anti-MAP1LC3A antibody produced in mouse, clone 1D5, purified immunoglobulin, buffered aqueous solution